Butrans 20 20 mcg (Buprenorphine PATCH) 20 MCG

BuTrans 20 mcg patches provide transdermal delivery of buprenorphine for pain management. This opioid analgesic is designed for continuous, long-lasting relief.

Strength

20 MCG

Pack Size

Manufacturer / TM Owner

PURDUE PHARMA

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

BuTrans 20 mcg patches are used for the management of moderate to severe chronic pain. Buprenorphine, the active ingredient, is a partial opioid agonist that works by binding to opioid receptors in the brain. This medication is typically prescribed for individuals who require around-the-clock pain relief and for whom alternative treatments are inadequate.

Side Effects

Common effects of BuTrans 20 mcg patches may include mild to moderate skin irritation at the application site, nausea, constipation, and dizziness. Some users may also experience headaches or drowsiness. These effects vary among individuals and are not experienced by everyone.

Precautions & Warnings

BuTrans 20 mcg patches should be applied to clean, dry, and intact skin. Avoid applying the patch to areas with cuts, rashes, or irritation. It is important to follow the healthcare provider's instructions for proper application and removal. Keep the patches out of reach of children and pets.

Avoid Interactions

BuTrans 20 mcg patches may interact with other medications, including other opioids, benzodiazepines, and certain antidepressants. Alcohol consumption should be avoided while using this medication, as it can increase the risk of side effects. Always consult a healthcare provider before starting or stopping any medication.

Frequently Asked Questions

BuTrans 20 mcg patches are used for the management of moderate to severe chronic pain that requires continuous, long-lasting relief.

Apply the patch to clean, dry, and intact skin, following the healthcare provider's instructions for proper application and removal.

Common side effects may include skin irritation, nausea, constipation, dizziness, headaches, and drowsiness.

It is recommended to avoid alcohol while using BuTrans 20 mcg patches, as it can increase the risk of side effects.

Store BuTrans 20 mcg patches at room temperature, away from moisture and heat, and keep them out of reach of children and pets.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.